Turns out Java can do serverless right — with GraalVM and Spring, cold starts are tamed and performance finally heats up.
Sarepta Therapeutics has followed through on its promise to file for accelerated approval of its gene therapy SRP-9001 for Duchenne muscular dystrophy (DMD), as it aims for a launch in the middle of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback